EIF5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.459200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.016800E-01
Normal-vs-Stage2
5.055600E-01
Normal-vs-Stage3
5.569800E-01
Normal-vs-Stage4
1.079570E-01
Stage1-vs-Stage2
4.401800E-01
Stage1-vs-Stage3
4.611800E-01
Stage1-vs-Stage4
6.218000E-02
Stage2-vs-Stage3
5.764200E-01
Stage2-vs-Stage4
1.158180E-01
Stage3-vs-Stage4
6.157400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.588000E-01
Normal-vs-AfricanAmerican
3.597200E-01
Normal-vs-Asian
9.937600E-01
Caucasian-vs-AfricanAmerican
3.726200E-01
Caucasian-vs-Asian
2.646800E-01
AfricanAmerican-vs-Asian
1.299830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.618800E-01
Normal-vs-Female
5.271400E-01
Male-vs-Female
9.036200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.656000E-01
Normal-vs-Age(41-60Yrs)
4.088000E-01
Normal-vs-Age(61-80Yrs)
6.147400E-01
Normal-vs-Age(81-100Yrs)
5.351200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.028800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.288400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.796000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.114200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.244000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.629800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.400800E-01
Normal-vs-Daily Drinker
8.592400E-01
Normal-vs-Weekly Drinker
5.494000E-01
Normal-vs-Occasional Drinker
3.965400E-01
Normal-vs-Social Drinker
5.792400E-01
Non Drinker-vs-Daily Drinker
4.174200E-01
Non Drinker-vs-Weekly Drinker
2.766600E-01
Non Drinker-vs-Occasional Drinker
1.250970E-01
Non Drinker-vs-Social Drinker
3.112000E-01
Daily Drinker-vs-Weekly Drinker
1.254980E-01
Daily Drinker-vs-Occasional Drinker
4.292300E-02
Daily Drinker-vs-Social Drinker
1.430170E-01
Weekly Drinker-vs-Occasional Drinker
8.516000E-01
Weekly Drinker-vs-Social Drinker
9.553200E-01
Occasional Drinker-vs-Social Drinker
8.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.129400E-01
Normal-vs-Grade 2
5.418600E-01
Normal-vs-Grade 3
8.216800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.698000E-02
Grade 1-vs-Grade 3
1.532600E-01
Grade 1-vs-Grade 4
9.129400E-01
Grade 2-vs-Grade 3
8.280400E-01
Grade 2-vs-Grade 4
5.418600E-01
Grade 3-vs-Grade 4
8.216800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.354400E-01
Normal-vs-NonDiabetic
6.658600E-01
Diabetic-vs-NonDiabetic
9.015800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.014000E-01
Normal-vs-NoPancreatitis
6.301200E-01
Pancreatitis-vs-NoPancreatitis
1.562080E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.030000E-01
Normal-vs-N1
4.836400E-01
N0-vs-N1
7.103800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.440000E-01
Normal-vs-TP53-NonMutant
6.496400E-01
TP53-Mutant-vs-TP53-NonMutant
7.795600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
